Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Vistagen Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 46 | 42 | −4 |
| Shares | 17.6M | 17.3M | −296.5K (−1.7%) |
| Value | $90.0M | $90.8M | +$839.3K (+0.9%) |
New holders (7)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 288,885 | $1.53M | 0.00% |
| Renaissance Technologies LLC | 109,800 | $580.0K | 0.00% |
| Millennium Management LLC | 36,498 | $192.7K | 0.00% |
| Acadian Asset Management LLC | 32,291 | $169.0K | 0.00% |
| American Century Companies Inc | 20,331 | $107.3K | 0.00% |
| ExodusPoint Capital Management, LP | 18,443 | $97.0K | 0.00% |
| Farther Finance Advisors, LLC | 81 | $437 | 0.00% |
Sold out (11)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Bank of Montreal | 96,900 | $524.2K |
| DAFNA Capital Management LLC | 41,886 | $215.3K |
| Jane Street Group, LLC | 21,940 | $112.8K |
| Virtu Financial LLC | 15,524 | $80.0K |
| Bank of New York Mellon Corp | 15,171 | $78.0K |
| Simplex Trading, LLC | 12,371 | $63.0K |
| Janney Montgomery Scott LLC | 10,000 | $51.0K |
| Royal Bank of Canada | 1,437 | $7.00K |
| First Manhattan Co | 333 | $1.71K |
| Cutler Group LP | 200 | $1.00K |
| EverSource Wealth Advisors, LLC | 88 | $452 |